Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
2.
3.

Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.

Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.

Cancer Res. 2004 Aug 1;64(15):5200-11.

4.

[Expression characteristics of transforming growth factor-beta1 in human skin at different development stages of gestation].

Chen W, Fu XB, Ge SL, Sun TZ, Jiang DY, Zhou G, Sheng ZY.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Apr;16(4):206-9. Chinese.

PMID:
15068708
5.

Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1.

Piek E, Westermark U, Kastemar M, Heldin CH, van Zoelen EJ, Nistér M, Ten Dijke P.

Int J Cancer. 1999 Mar 1;80(5):756-63.

6.

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.

Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB.

J Biol Chem. 2001 Jun 8;276(23):19945-53. Epub 2001 Mar 21.

7.

Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.

Wang H, Yang GH, Bu H, Zhou Q, Guo LX, Wang SL, Ye L.

Int J Exp Pathol. 2003 Jun;84(3):153-63.

8.

The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.

Poncelet AC, de Caestecker MP, Schnaper HW.

Kidney Int. 1999 Oct;56(4):1354-65.

9.

The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice.

Yang X, Li C, Xu X, Deng C.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3667-72.

11.

Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis.

Ito Y, Sarkar P, Mi Q, Wu N, Bringas P Jr, Liu Y, Reddy S, Maxson R, Deng C, Chai Y.

Dev Biol. 2001 Aug 1;236(1):181-94.

12.

Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.

Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.

J Cell Physiol. 1998 Jun;175(3):305-13.

PMID:
9572475
13.

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K, ten Dijke P.

EMBO J. 1997 Sep 1;16(17):5353-62.

14.

Functions of mammalian Smad genes as revealed by targeted gene disruption in mice.

Weinstein M, Yang X, Deng C.

Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):49-58. Review.

PMID:
10708952
15.

Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.

Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.

Cancer Res. 2000 Aug 15;60(16):4507-12.

17.

Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo.

Quan T, He T, Kang S, Voorhees JJ, Fisher GJ.

J Invest Dermatol. 2002 Aug;119(2):499-506.

18.

TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.

Nakagawa T, Li JH, Garcia G, Mu W, Piek E, Böttinger EP, Chen Y, Zhu HJ, Kang DH, Schreiner GF, Lan HY, Johnson RJ.

Kidney Int. 2004 Aug;66(2):605-13.

19.

Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice.

Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ.

Development. 1995 Jun;121(6):1845-54.

20.

Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells.

Sinha S, Hoofnagle MH, Kingston PA, McCanna ME, Owens GK.

Am J Physiol Cell Physiol. 2004 Dec;287(6):C1560-8. Epub 2004 Aug 11.

Supplemental Content

Support Center